Manufacturing models permitting roll out/scale out of clinically led autologous cell therapies: regulatory and scientific challenges for comparability. (2014)
Attributed to:
EPSRC Centre for Innovative Manufacturing in Regenerative Medicine
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jcyt.2014.03.005
PubMed Identifier: 24856894
Publication URI: http://europepmc.org/abstract/MED/24856894
Type: Journal Article/Review
Volume: 16
Parent Publication: Cytotherapy
Issue: 8
ISSN: 1465-3249